Premium
Response of pemphigus vulgaris to anti‐CD20 antibody therapy (rituximab) may be delayed
Author(s) -
Belgi A. S.,
Azeez M.,
Hoyle C.,
Williams R. E. A.
Publication year - 2006
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.2005.01941.x
Subject(s) - medicine , rituximab , pemphigus vulgaris , methylprednisolone , azathioprine , exacerbation , prednisolone , gastroenterology , corticosteroid , surgery , dermatology , immunology , antibody , disease